tiprankstipranks

New Portfolio - New Portfolio

Jason Moore

New Portfolio
Individual Investor
Ranked #350,298 out of 747,498 TipRanks' Investors
Success Rate
38%
39 out of 104
profitable transactions
Average Return
16.58%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.16%
6-Month Return▲ 16.04%
12-Month Return-
YTD Return▼ 11.75%
Total Return▼ 11.75%

Best Trade

Opened at
Closed at-
Gain▲ 2583.65%

Bio

Performance

29.87%0-29.87%
▲ 5.14%
▲ 4.57%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 20.97%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 22.18%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 2.00%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 13.38%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 2.86%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.22%
Jun 2024
▲ 29.87%
▲ 0.88%
▲ 9.28%
Jul 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.14%▲ 4.57%
▼ 1.87%▲ 1.59%▼ 20.97%
▲ 14.08%▲ 5.22%▲ 22.18%
▲ 5.05%▲ 3.27%▼ 2.00%
▼ 12.40%▼ 4.03%▼ 13.38%
▲ 11.46%▲ 5.06%▲ 2.86%
▼ 2.25%▲ 3.53%▼ 4.22%
▲ 29.87%▲ 0.88%▲ 9.28%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Avidity Biosciences
0.97%
▲ 110.25%
1
Open
Mar 08, 2024
Ocuphire Pharma
0.97%
0.00%
1
Open
Mar 08, 2024
NRX Pharmaceuticals
0.97%
▼ 62.02%
1
Open
Mar 08, 2024
Abeona Therapeutics
0.97%
▼ 35.88%
1
Open
Mar 08, 2024
Cardio Diagnostics Holdings
0.97%
▼ 62.77%
1
Open
Mar 08, 2024
Infobird Co
0.97%
▼ 53.09%
1
Open
Mar 08, 2024
Ocean Biomedical
0.97%
▼ 80.22%
1
Open
Mar 08, 2024
Akebia Therapeutics
0.97%
▼ 8.16%
1
Open
Mar 08, 2024
Agenus
0.97%
▼ 55.30%
1
Open
Mar 08, 2024
Legend Biotech
0.97%
▼ 7.13%
1
Open
Mar 08, 2024
Theratechnologies
0.97%
▲ 28.93%
1
Open
Mar 08, 2024
BeiGene
0.97%
▼ 2.38%
1
Open
Mar 08, 2024
Optinose
0.97%
▼ 36.90%
1
Open
Mar 08, 2024
Supernus Pharmaceuticals
0.97%
▼ 2.64%
1
Open
Mar 08, 2024
Cardiff Oncology
0.97%
▼ 45.65%
1
Open
Mar 08, 2024
Vanda
0.97%
▲ 57.88%
1
Open
Mar 08, 2024
Geron
0.97%
▲ 104.44%
1
Open
Mar 08, 2024
Liquidia Technologies
0.97%
▼ 21.08%
1
Open
Mar 08, 2024
Esperion
0.97%
▲ 9.13%
1
Open
Mar 08, 2024
2seventy bio
0.97%
▼ 5.30%
1
Open
Mar 08, 2024